Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells
- 22 January 2004
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 46 (4) , 562-569
- https://doi.org/10.1016/j.neuropharm.2003.10.015
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Different toxicological profile of two COMT inhibitors in vivo: the role of uncoupling effects.Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Effects of entacapone and tolcapone on mitochondrial membrane potentialEuropean Journal of Pharmacology, 2002
- Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- Cytochrome c-mediated Apoptosis in Cells Lacking Mitochondrial DNAJournal of Biological Chemistry, 1999
- The mitochondrial permeability transition poreBiochemical Society Symposia, 1999
- Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNAEuropean Journal of Biochemistry, 1999
- Tolcapone and fulminant hepatitisThe Lancet, 1998
- Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.British Journal of Clinical Pharmacology, 1995
- Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by ComplementationScience, 1989
- The role of adenine nucleotide translocation in the energization of the inner membrane of mitochondria isolated from ϱ+ and ϱo strains of saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 1985